Search Results - "WEITZNER, M. A"

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients by Meyers, C A, Weitzner, M A, Valentine, A D, Levin, V A

“…Patients with malignant glioma develop progressive neurobehavioral deficits over the course of their illness. These are caused both by the effects of the…”
Get more information

The Caregiver Quality of Life Index-Cancer (CQOLC) Scale: Development and Validation of an Instrument to Measure Quality of Life of the Family Caregiver of Patients with Cancer by M. A. Weitzner, P. B. Jacobsen, H. Wagner, Jr, J. Friedland, Cox, C.

“…Family caregivers have become increasingly responsible for providing home care for cancer patients. Research has documented the distress of family caregivers;…”
Get full text

Family Caregiver Quality of Life: Differences Between Curative and Palliative Cancer Treatment Settings by Weitzner, Michael A, McMillan, Susan C, Jacobsen, Paul B

“…To compare the impact of cancer caregiving in curative and palliative settings on family caregiver quality of life (QOL), 267 family caregivers of cancer…”
Get full text

Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy by WEITZNER, M. A, MEYERS, C. A, STUEBING, K. K, SALEEBA, A. K

“…This study sought to compare the mood and quality of life (QOL) of breast cancer survivors with those observed in low-risk breast cancer screening patients. A…”
Get full text

Psychosocial and Neuropsychiatric Aspects of Patients with Primary Brain Tumors by Weitzner, Michael A.

“…Primary brain tumors are increasing in incidence in the United States and are devastating to patients and families. Because brain tumors and their treatment…”
Get full text

Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment by Weitzner, M A, Meyers, C A, Valentine, A D

“…Psychostimulants used in the treatment of psychiatric conditions, including depression, alleviate some of the observed psychomotor retardation. We describe 3…”
Get more information

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors by Weitzner, M A, Meyers, C A, Gelke, C K, Byrne, K S, Cella, D F, Levin, V A

“…This report describes the development and validation of a brain subscale for the Functional Assessment of Cancer Therapy (FACT) scale, and the revalidation of…”
Get more information

A retrospective study of the psychiatric management and outcome of delirium in the cancer patient by OLOFSSON, S. M, WEITZNER, M. A, VALENTINE, A. D, BAILE, W. F, MEYERS, C. A

“…This report describes the evaluation and treatment of delirium in the cancer patient in a major comprehensive cancer center. Ninety consecutive cases of…”
Get full text

Cognitive Functioning and Quality of Life in Malignant Glioma Patients: A Review of the Literature by Weitzner, Michael A., Meyers, Christina A.

“…The state of current research in the psychosocial and neurocognitive functioning of primary brain tumor patients, particularly those with gliomas, is reviewed…”
Get full text

The family caregiver of the older cancer patient by Weitzner, M A, Haley, W E, Chen, H

“…Cancer care is becoming increasingly complex. The health care practices of the present day make it imperative that the family provide assistance in the…”
Get more information

Patients with malignant meningitis presenting with neuropsychiatric manifestations by Weitzner, M A, Olofsson, S M, Forman, A D

“…Malignant meningitis is often thought of as a late event in the course of cancer. At one time, it was thought to be rare, but it has been recognized more…”
Get more information

A Pilot Trial of Paroxetine for the Treatment of Hot Flashes and Associated Symptoms in Women with Breast Cancer by Weitzner, Michael A, Moncello, Joanne, Jacobsen, Paul B, Minton, Susan

“…Abrupt onset of hot flashes poses a significant problem for women treated with chemotherapy for breast cancer. Alternatives to hormone replacement, such as the…”
Get full text

The impact of pituitary disease on the family caregiver and overall family functioning by Weitzner, M A, Knutzen, R

“…Chronic medical illness not only affects the patient but the entire family. The family system undergoes a tremendous change in focus during the acute illness,…”
Get more information

Quality of life and neurobehavioural functioning in patients with malignant gliomas by Weitzner, M A, Meyers, C A

Get more information

Psychosocial functioning and quality of life in patients with primary brain tumors by Weitzner, M A, Meyers, C A, Byrne, K

“…Perceived quality of life (QOL) was evaluated in a group of 50 patients with primary brain tumors. Participants completed two QOL measures and a demographic…”
Get full text

The Caregiver Quality of Life Index-Cancer (CQOLC) Scale: revalidation in a home hospice setting by Weitzner, M A, McMillan, S C

“…Hospices provide palliative care to persons who are dying and supportive care to their family caregivers. As death approaches, these family caregivers become…”
Get full text

Neuropsychiatry and pituitary disease: an overview by Weitzner, M A

“…It has been recognized for some time that psychiatric symptoms, such as depression, anxiety, and behavioral alterations, may occur in patients who have…”
Get more information

Borderline personality disorder and bone marrow transplantation: ethical considerations and review by Weitzner, Michael A., Lehninger, Frank, Sullivan, Daniel, Fields, Karen K.

“…Bone marrow transplantation (BMT) is rapidly becoming a part of conventional cancer treatment. However, it remains a ‘last‐ditch’ treatment option for patients…”
Get full text

Neurobehavioral functioning and quality of life in patients treated for cancer of the central nervous system by Meyers, Christina A, Weitzner, Michael A

“…There are relatively few studies that systematically address the cognitive and emotional functioning of brain tumor patients. Several conclusions, however, can…”
Get full text

An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM) by Smith, T. J., Coyne, P. J., Staats, P. S., Deer, T., Stearns, L. J., Rauck, R. L., Boortz-Marx, R. L., Buchser, E., Català, E., Bryce, D. A., Cousins, M., Pool, G. E.

“…Background:: The randomized clinical trial of implantable drug delivery systems (IDDS) plus comprehensive medical management (CMM) versus CMM alone showed…”
Get full text